Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Ferga C. Gleeson, Jesse S. Voss, Benjamin R. Kipp, Sarah E. Kerr, John S. Van Arnam, John R. Mills, Cherisse A. Marcou, Amber R. Schneider, Zheng Jin Tu, Michael R. Henry, Michael J. Levy
Published Jun 28, 2017 · Vol. 8, No. 55 · pp. 93464-93475
Sonja I. Buschow, Matteo Ramazzotti, Inge M.J. Reinieren-Beeren, Lucie M. Heinzerling, Harm Westdorp, Irene Stefanini, Luca Beltrame, Stanleyson V. Hato, Eva Ellebaek, Stefanie Gross, Van Anh Nguyen, Georg Weinlich, Jiannis Ragoussis, Dilair Baban, Beatrice Schuler-Thurner, Inge M. Svane, Nikolaus Romani, Jonathan M. Austyn, I. Jolanda M. De Vries, Gerold Schuler, Duccio Cavalieri, Carl G. Figdor
Published Jun 27, 2017 · Vol. 8, No. 40 · pp. 67439-67456